News
CALZF
0.600
NaN%
--
PolyNovo Appoints New Director With No Current Securities Interests
TipRanks · 3d ago
PolyNovo strengthens board with appointment of Dr Charmaine Gittleson
TipRanks · 03/24 07:57
PolyNovo Director Robert Douglas Acquires Initial Stake of 151,000 Shares
TipRanks · 03/16 23:48
PolyNovo Director Andrew Lumsden Doubles Indirect Shareholding
TipRanks · 02/27 02:49
Analysts Are Bullish on These Healthcare Stocks: Xencor (XNCR), Polynovo (CALZF)
TipRanks · 02/25 22:50
PolyNovo Posts H1 FY26 Investor Call Recording as NovoSorb Platform Supports Global Growth
TipRanks · 02/25 00:04
Polynovo Earnings Call Highlights Strong Growth Momentum
TipRanks · 02/23 00:21
Polynovo (CALZF) Receives a Buy from Bell Potter
TipRanks · 02/23 00:05
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 02/22 23:40
Macquarie Remains a Buy on Polynovo (CALZF)
TipRanks · 02/22 23:36
PolyNovo Sets Webcast to Present H1 FY26 Results
TipRanks · 02/20 00:49
PolyNovo lifts half-year sales and capacity as new CEO targets next growth phase
TipRanks · 02/20 00:49
PolyNovo Expands Balkan Reach With New NovoSorb Distributor
TipRanks · 02/01 22:28
Macquarie Sticks to Their Buy Rating for Polynovo (CALZF)
TipRanks · 01/27 00:35
Macquarie Keeps Their Buy Rating on Polynovo (CALZF)
TipRanks · 01/20 00:36
PolyNovo Delivers Strong 1H26 Growth, Boosts Cash and Capacity as NovoSorb Adoption Accelerates
TipRanks · 01/18 22:27
Positive Report for Polynovo (CALZF) from Morgans
TipRanks · 12/11/2025 22:35
PolyNovo Appoints New Company Secretary and General Counsel
TipRanks · 12/08/2025 02:37
Polynovo (CALZF) Gets a Buy from Canaccord Genuity
TipRanks · 12/08/2025 02:35
PolyNovo Highlights Industry Position at Bell Potter Healthcare Conference
TipRanks · 11/17/2025 23:47
More
Webull provides a variety of real-time CALZF stock news. You can receive the latest news about Polynovo through multiple platforms. This information may help you make smarter investment decisions.
About CALZF
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.